Preferred Label : venoms;
MeSH definition : Poisonous animal secretions forming fluid mixtures of many different enzymes, toxins,
and other substances. These substances are produced in specialized glands and secreted
through specialized delivery systems (nematocysts, spines, fangs, etc.) for disabling
prey or predator.;
MeSH synonym : venom;
MeSH annotation : general or unspecified only: prefer specifics; coordinate with the animal producing
the venom but many specific precoordinated venom terms are available (AMPHIBIAN VENOMS;
ARTHROPOD VENOMS; SNAKE VENOMS & its indentions, etc.);
Is substance : O;
Origin ID : D014688;
UMLS CUI : C0042479;
Allowable qualifiers
Currated CISMeF NLP mapping
Indexing information
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Related MeSH term(s)
See also
See also inter- (CISMeF)
Semantic type(s)
Poisonous animal secretions forming fluid mixtures of many different enzymes, toxins,
and other substances. These substances are produced in specialized glands and secreted
through specialized delivery systems (nematocysts, spines, fangs, etc.) for disabling
prey or predator.
https://www.has-sante.fr/portail/jcms/c_2897004/en/bydureon
2018
false
false
false
France
exenatide
evaluation of the transparency committee
injections
suspension, nos
Set, Psychology
suspensions
injection, nos
device, nos
Complement
Injection moulding
long
devices
Grassland
equipment and supplies
peptides
venoms
Exenatide
---
https://www.has-sante.fr/portail/jcms/c_2877302/fr/bydureon
https://www.has-sante.fr/portail/jcms/c_2877302/fr/bydureon-exenatide-antidiabetique
2018
false
false
false
France
treatment outcome
drug therapy, combination
hypoglycemic agents
diabetes mellitus, type 2
insulin
metformin
exenatide
incretins
insurance, health, reimbursement
adult
Glycated Hemoglobin
injections, subcutaneous
guidelines for drug use
evaluation of the transparency committee
peptides
venoms
Exenatide
---
http://www.riziv.fgov.be/SiteCollectionDocuments/consensus_litterature_resume_20161117.pdf
2016
false
false
false
Belgium
French
GLP-1 Mimetics
diabetes mellitus, type 2
review of literature
consensus
GLP-1 Mimetics
treatment outcome
albiglutide
albiglutide
Glucagon-like peptide-1 (GLP-1) analogues
drug therapy, combination
metformin
hypoglycemic agents
hypoglycemic agents
glimepiride
dulaglutide
dulaglutide
Liraglutide
Liraglutide
Sitagliptin Phosphate
sulfonylurea compounds
comparative effectiveness research
arterial pressure
insulin
thyroid neoplasms
pancreatitis
Injection Site Reaction
cardiovascular diseases
practice guidelines as topic
Evidence-Based medicine
rGLP-1 protein
rGLP-1 protein
glucagon-like peptide 1
glucagon-like peptide 1
glucagon-like peptide 1
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
glucagon-like peptides
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
peptides
venoms
peptides
venoms
thiazolidinediones
Pioglitazone
Exenatide
Exenatide
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=66105532
2015
false
false
false
France
French
summary of product characteristics
package leaflet
evaluation of the transparency committee
peptides
venoms
Exenatide
---
http://www.franceculture.fr/emission-continent-sciences-universalite-des-venins-2015-11-30
2015
false
false
false
France
French
venoms
health technology assessment
---
http://www.has-sante.fr/portail/jcms/c_2000727/fr/bydureon
2014
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
diabetes mellitus, type 2
treatment outcome
injections, subcutaneous
hypoglycemic agents
hypoglycemic agents
Delayed-Action preparations
glucagon-like peptide 1
drug therapy, combination
adult
Pre-filled Pen Syringe
insurance, health, reimbursement
exenatide
peptides
venoms
peptides
venoms
Exenatide
Exenatide
---
http://www.has-sante.fr/portail/jcms/c_2038301/fr/byetta
2014
false
false
false
France
French
evaluation of the transparency committee
drug therapy, combination
metformin
incretins
incretins
insulin
hypoglycemic agents
hypoglycemic agents
treatment outcome
insurance, health, reimbursement
diabetes mellitus, type 2
adult
injections, subcutaneous
Sulfonylurea Antidiabetic Agent
sulfonylurea compounds
exenatide
peptides
venoms
peptides
venoms
Exenatide
Exenatide
---
http://www.has-sante.fr/portail/jcms/c_1778488/fr/byetta
http://www.has-sante.fr/portail/jcms/c_517640/fr/byetta?xtmc=&xtcr=2
2014
false
false
false
France
French
evaluation of the transparency committee
drug therapy, combination
metformin
incretins
incretins
insulin
hypoglycemic agents
hypoglycemic agents
treatment outcome
insurance, health, reimbursement
diabetes mellitus, type 2
adult
injections, subcutaneous
exenatide
peptides
venoms
peptides
venoms
Exenatide
Exenatide
---
https://minerva-ebp.be/fr/article/102
2013
false
false
minerva-ebm.be
Belgium
French
diabetes mellitus, type 2
critical appraisal or critical reading
hypoglycemic agents
treatment outcome
peptides
venoms
sulfonylurea compounds
---
https://www.ema.europa.eu/medicines/human/EPAR/Byetta
2012
false
United Kingdom
French
English
syndication feed
Glucagon-Like Peptide-1 Receptor
exenatide
aged
drug interactions
pregnancy
breast feeding
peptides
venoms
hypoglycemic agents
diabetes mellitus, type 2
drug evaluation, preclinical
drug storage
drug approval
drug labeling
peptides
hypoglycemic agents
venoms
treatment outcome
injections, subcutaneous
drug therapy, combination
adult
drug evaluation
summary of product characteristics
package leaflet
Exenatide
Exenatide
---
https://rmlg.uliege.be/article/1950
2009
Belgium
journal article
hypersensitivity
venoms
risk-taking
laboratories
case management
hymenoptera
---
https://minerva-ebp.be/fr/article/540
2008
false
false
minerva-ebm.be
Belgium
French
diabetes mellitus, type 2
drug therapy, combination
treatment outcome
hypoglycemic agents
peptides
venoms
peptides
venoms
critical appraisal or critical reading
Exenatide
---
http://www.has-sante.fr/portail/display.jsp?id=c_455022
2006
France
evaluation of the transparency committee
powders
injections
venoms
---
http://www.has-sante.fr/portail/display.jsp?id=c_455000
2006
France
evaluation of the transparency committee
venoms
powders
injections
---